Morten Sogaard, VP Target Sciences at Pfizer oversees genetics, functional genomics, computational biology and target validation group as well as “Innovative target exploration networks” to generate first in class targets from emerging science, and he also oversees companion diagnostics at Pfizer. Previously he helped define and implement Pfizer’s R&D data, AI and platform technology investment strategies and external innovation.

Morten received his Ph.D.  from University of Copenhagen and did postdoctoral studies with Nobel laureate Jim Rothman at MSKCC. He started his industry career at Pharmacia, where he immune oncology biologics discovery, then moved on to AstraZeneca and Boehringer Ingelheim where he had senior roles leading biotechnology and genomics platform capabilities, and also briefly served as Head of R&D Informatics at BI.